Logo image of 1C3.MI

C3.AI INC-A (1C3.MI) Stock Fundamental Analysis

BIT:1C3 - Euronext Milan - US12468P1049 - Common Stock - Currency: EUR

20.955  -0.28 (-1.32%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 1C3. 1C3 was compared to 102 industry peers in the Software industry. While 1C3 has a great health rating, there are worries on its profitability. 1C3 is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year 1C3 has reported negative net income.
In the past year 1C3 has reported a negative cash flow from operations.
1C3 had negative earnings in each of the past 5 years.
1C3 had a negative operating cash flow in each of the past 5 years.
1C3.MI Yearly Net Income VS EBIT VS OCF VS FCF1C3.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -100M -200M -300M

1.2 Ratios

1C3's Return On Assets of -28.14% is on the low side compared to the rest of the industry. 1C3 is outperformed by 83.33% of its industry peers.
1C3 has a Return On Equity of -34.44%. This is in the lower half of the industry: 1C3 underperforms 75.49% of its industry peers.
Industry RankSector Rank
ROA -28.14%
ROE -34.44%
ROIC N/A
ROA(3y)-26.48%
ROA(5y)-20.1%
ROE(3y)-31.79%
ROE(5y)-24.01%
ROIC(3y)N/A
ROIC(5y)N/A
1C3.MI Yearly ROA, ROE, ROIC1C3.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

1.3 Margins

1C3's Gross Margin of 60.62% is in line compared to the rest of the industry. 1C3 outperforms 43.14% of its industry peers.
1C3's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for 1C3 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.75%
GM growth 5Y-4.23%
1C3.MI Yearly Profit, Operating, Gross Margins1C3.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

8

2. Health

2.1 Basic Checks

1C3 does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 1C3 has more shares outstanding
1C3 has more shares outstanding than it did 5 years ago.
There is no outstanding debt for 1C3. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1C3.MI Yearly Shares Outstanding1C3.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
1C3.MI Yearly Total Debt VS Total Assets1C3.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 8.60 indicates that 1C3 is not in any danger for bankruptcy at the moment.
1C3 has a Altman-Z score of 8.60. This is amongst the best in the industry. 1C3 outperforms 84.31% of its industry peers.
There is no outstanding debt for 1C3. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.6
ROIC/WACCN/A
WACC9.02%
1C3.MI Yearly LT Debt VS Equity VS FCF1C3.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 6.86 indicates that 1C3 has no problem at all paying its short term obligations.
1C3's Current ratio of 6.86 is amongst the best of the industry. 1C3 outperforms 92.16% of its industry peers.
1C3 has a Quick Ratio of 6.86. This indicates that 1C3 is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 6.86, 1C3 belongs to the top of the industry, outperforming 93.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.86
Quick Ratio 6.86
1C3.MI Yearly Current Assets VS Current Liabilites1C3.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

1C3 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.22%, which is quite good.
1C3 shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.27%.
The Revenue has been growing by 19.95% on average over the past years. This is quite good.
EPS 1Y (TTM)15.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.45%
Revenue 1Y (TTM)25.27%
Revenue growth 3Y15.45%
Revenue growth 5Y19.95%
Sales Q2Q%25.56%

3.2 Future

The Earnings Per Share is expected to grow by 25.04% on average over the next years. This is a very strong growth
1C3 is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.07% yearly.
EPS Next Y-9.4%
EPS Next 2Y13.01%
EPS Next 3Y30.08%
EPS Next 5Y25.04%
Revenue Next Year19.73%
Revenue Next 2Y19.6%
Revenue Next 3Y21.53%
Revenue Next 5Y34.07%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1C3.MI Yearly Revenue VS Estimates1C3.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B
1C3.MI Yearly EPS VS Estimates1C3.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

1

4. Valuation

4.1 Price/Earnings Ratio

1C3 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year 1C3 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1C3.MI Price Earnings VS Forward Price Earnings1C3.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1C3.MI Per share data1C3.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

A more expensive valuation may be justified as 1C3's earnings are expected to grow with 30.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.01%
EPS Next 3Y30.08%

0

5. Dividend

5.1 Amount

1C3 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

C3.AI INC-A

BIT:1C3 (6/18/2025, 7:00:00 PM)

20.955

-0.28 (-1.32%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-28 2025-05-28/amc
Earnings (Next)09-02 2025-09-02/amc
Inst Owners52.47%
Inst Owner ChangeN/A
Ins Owners7.49%
Ins Owner ChangeN/A
Market Cap2.78B
Analysts52.5
Price Target27.16 (29.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.05%
Min EPS beat(2)22.69%
Max EPS beat(2)53.41%
EPS beat(4)4
Avg EPS beat(4)50.96%
Min EPS beat(4)22.69%
Max EPS beat(4)64.04%
EPS beat(8)8
Avg EPS beat(8)50.5%
EPS beat(12)12
Avg EPS beat(12)48.95%
EPS beat(16)15
Avg EPS beat(16)42.7%
Revenue beat(2)0
Avg Revenue beat(2)-2.13%
Min Revenue beat(2)-2.24%
Max Revenue beat(2)-2.02%
Revenue beat(4)1
Avg Revenue beat(4)-1.56%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)0.62%
Revenue beat(8)1
Avg Revenue beat(8)-1.61%
Revenue beat(12)2
Avg Revenue beat(12)-1.5%
Revenue beat(16)3
Avg Revenue beat(16)-1.23%
PT rev (1m)0.83%
PT rev (3m)N/A
EPS NQ rev (1m)-21.95%
EPS NQ rev (3m)2.06%
EPS NY rev (1m)2.78%
EPS NY rev (3m)20.82%
Revenue NQ rev (1m)-2.7%
Revenue NQ rev (3m)-3.28%
Revenue NY rev (1m)-1.65%
Revenue NY rev (3m)-2.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.23
P/FCF N/A
P/OCF N/A
P/B 3.82
P/tB 3.82
EV/EBITDA N/A
EPS(TTM)-0.34
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS2.55
BVpS5.49
TBVpS5.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.14%
ROE -34.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.62%
FCFM N/A
ROA(3y)-26.48%
ROA(5y)-20.1%
ROE(3y)-31.79%
ROE(5y)-24.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.75%
GM growth 5Y-4.23%
F-Score4
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 24.11%
Cap/Sales 0.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.86
Quick Ratio 6.86
Altman-Z 8.6
F-Score4
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)472.89%
Cap/Depr(5y)307.85%
Cap/Sales(3y)12.2%
Cap/Sales(5y)7.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.45%
EPS Next Y-9.4%
EPS Next 2Y13.01%
EPS Next 3Y30.08%
EPS Next 5Y25.04%
Revenue 1Y (TTM)25.27%
Revenue growth 3Y15.45%
Revenue growth 5Y19.95%
Sales Q2Q%25.56%
Revenue Next Year19.73%
Revenue Next 2Y19.6%
Revenue Next 3Y21.53%
Revenue Next 5Y34.07%
EBIT growth 1Y-1.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.87%
EBIT Next 3Y24.81%
EBIT Next 5YN/A
FCF growth 1Y50.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.6%
OCF growth 3YN/A
OCF growth 5YN/A